6 Reasons Why AGP Could Rise to PKR 265 Soon

2: AGP Is Gaining Market Share Through Volume Growth

Volumes Are Growing Despite Industry Stagnation

AGP has continued to grow volumes while the overall pharmaceutical industry has struggled.

Key indicators show:

📢 Announcement: You can now access our services and similar analyses by opening an account with us via JS Global

• AGP revenue growth in 9MCY25 of 15 percent year on year
  
• Expected CY25 revenue growth of 17 percent
  
• AGP volume growth of 3.9 percent
  
• Industry volume growth of minus 0.1 percent
  

This points to market share gains rather than price driven growth.

Core Brands Are Driving Demand

AGP’s portfolio includes well established brands such as Azomax, Rigix, Norvasc, Osnate D, and Anafortan Plus. These brands support consistent prescriptions and repeat demand.

⚠️ This post reflects the author’s personal opinion and is for informational purposes only. It does not constitute financial advice. Investing involves risk and should be done independently. Read full disclaimer →